{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:36:41Z","timestamp":1793911001484,"version":"4.8.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011302","name":"Children's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cmi.2026.09.005","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:51:25Z","timestamp":1789516285000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Standardizing outcomes in paediatric bloodstream infection antibiotic trials: a scoping review"],"prefix":"10.1016","author":[{"given":"Sophie C.H.","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha C.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Spurling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luregn","family":"Schlapbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N.A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.09.005_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S2352-4642(17)30010-X","article-title":"Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study","volume":"1","author":"Agyeman","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.cmi.2026.09.005_bib2","article-title":"Epidemiology of Bloodstream Infections in Hospitalized Children in the United States, 2009-2016","author":"Spaulding","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.09.005_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/INF.0000000000000339","article-title":"Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period","volume":"33","author":"Folgori","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2026.09.005_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016293","article-title":"Global shortage of neonatal and paediatric antibiotic trials: rapid review","volume":"7","author":"Thompson","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2026.09.005_bib5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/cid\/ciae341","article-title":"Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes","volume":"79","author":"Wen","year":"2024","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.cmi.2026.09.005_bib6","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/S1473-3099(16)00069-4","article-title":"Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review","volume":"16","author":"Folgori","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.09.005_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/sim.7561","article-title":"Five criteria for using a surrogate endpoint to predict treatment effect based on data from multiple previous trials","volume":"37","author":"Baker","year":"2018","journal-title":"Stat Med"},{"key":"10.1016\/j.cmi.2026.09.005_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jclinepi.2016.09.003","article-title":"Primary Outcomes Reporting in Trials (PORTal): a systematic review of inadequate reporting in pediatric randomized controlled trials","volume":"81","author":"Bhaloo","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cmi.2026.09.005_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"Clarke","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2026.09.005_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002148","article-title":"Core Outcome Set-STAndards for Reporting: The COS-STAR Statement","volume":"13","author":"Kirkham","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2026.09.005_bib11","first-page":"533","volume":"23","author":"Harris","year":"2017"},{"key":"10.1016\/j.cmi.2026.09.005_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.624639","article-title":"Model-Informed Precision Dosing of Antibiotics in Pediatric Patients: A Narrative Review","volume":"9","author":"Abdulla","year":"2021","journal-title":"Frontiers in Pediatrics"},{"key":"10.1016\/j.cmi.2026.09.005_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of Patient-Reported Outcomes in Randomized Trials: The CONSORT PRO Extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2026.09.005_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework AU - Arksey, Hilary","volume":"8","author":"O'Malley","year":"2005","journal-title":"International Journal of Social Research Methodology"},{"key":"10.1016\/j.cmi.2026.09.005_bib15","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2026.09.005_bib16","series-title":"Joanna Briggs Institute Reviewers\u2019 Manual: 2015 edition \/ Supplement","author":"Peters","year":"2015"},{"key":"10.1016\/j.cmi.2026.09.005_bib17","series-title":"The World by Income and Region","author":"Bank","year":"2024"},{"key":"10.1016\/j.cmi.2026.09.005_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13063-019-3452-y","article-title":"CASSETTE\u2014clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a randomised controlled trial","volume":"20","author":"Dotel","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2026.09.005_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/ciad666","article-title":"Early oral antibiotic switch in Staphylococcus aureus bacteraemia: the Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol","volume":"79","author":"Kretser","year":"2023","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.cmi.2026.09.005_bib20","series-title":"Ciprofloxacin Therapy for Neonates and Young Infants: A Clinical Pharmacological Perspective Including Pharmacokinetics (PK) and Pharmacodynamics (PD) [Thesis]","year":"2016"},{"key":"10.1016\/j.cmi.2026.09.005_bib21","series-title":"Study to assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants","author":"Shionogi","year":"2024"},{"key":"10.1016\/j.cmi.2026.09.005_bib22","series-title":"Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants","author":"Shionogi","year":"2024"},{"key":"10.1016\/j.cmi.2026.09.005_bib23","article-title":"NeoSep1: a study to determine the ranking of existing and new antibiotics combinations to treat newborn babies who are in hospital with severe sepsis","year":"2022","journal-title":"ISRCTN"},{"key":"10.1016\/j.cmi.2026.09.005_bib24","article-title":"Comparing two antibiotic regimens for the treatment of late onset sepsis in neonates","year":"2018","journal-title":"ANZCTR"},{"key":"10.1016\/j.cmi.2026.09.005_bib25","series-title":"Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection","year":"2016"},{"key":"10.1016\/j.cmi.2026.09.005_bib26","article-title":"Efficacy and Safety of Colistin Based Antibiotic Therapy","year":"2021","journal-title":"Clinicaltrialsgov"},{"key":"10.1016\/j.cmi.2026.09.005_bib27","series-title":"10 days vs 14 days antibiotic therapy in Gram negative bacterial sepsis in newborns","year":"2018"},{"key":"10.1016\/j.cmi.2026.09.005_bib28","series-title":"Single-arm Clinical Trial to Study the Safety, Efficacy and Pharmacokinetics of MK-3009 (Daptomycin) in Japanese Pediatric Participants Aged 1 to 17 Years With Complicated Skin and Soft Tissue Infections or Bacteremia Caused by Gram","year":"2018"},{"key":"10.1016\/j.cmi.2026.09.005_bib29","series-title":"Combination of intravenous and oral antibiotic therapy compared to intravenous antibiotic therapy for management of infection within first 3 days of life in newborn babies","year":"2024"},{"key":"10.1016\/j.cmi.2026.09.005_bib30","series-title":"Comparison of the Efficacy of a 7-day Versus 14-day Course of Intravenous Antibiotics in the Treatment of Uncomplicated Neonatal Bacterial Sepsis: a Randomized Controlled Non-inferiority Trial","year":"2019"},{"key":"10.1016\/j.cmi.2026.09.005_bib31","series-title":"To compare whether a 1 week course of antibiotics is as good as 2 weeks of antibiotics for septic newborn babies","year":"2017"},{"key":"10.1016\/j.cmi.2026.09.005_bib32","article-title":"Comparison of two courses [one long course-14 days, another short course-10 days] of antibiotic treatment for newborns suffering from sepsis","year":"2023","journal-title":"ICTRP"},{"key":"10.1016\/j.cmi.2026.09.005_bib33","article-title":"Efficacy and Safety of Colistin Based Antibiotic Therapy for Multidrug Resistant Gram Negative Infections in Pediatric Intensive Care Unit","year":"2021","journal-title":"Clinicaltrialsgov"},{"key":"10.1016\/j.cmi.2026.09.005_bib34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/jpids\/piab027","article-title":"Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics","volume":"10","author":"Woods","year":"2021","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"key":"10.1016\/j.cmi.2026.09.005_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.894005","article-title":"Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective","volume":"10","author":"Ting","year":"2022","journal-title":"Frontiers in Pediatrics"},{"key":"10.1016\/j.cmi.2026.09.005_bib36","first-page":"8","article-title":"Ten Days Versus Fourteen Days Antibiotic Therapy in Culture Proven Neonatal Sepsis: Single Center Egyptian Experience","volume":"17","author":"Salama","year":"2020","journal-title":"Pediatric Oncall Journal"},{"key":"10.1016\/j.cmi.2026.09.005_bib37","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/S1473-3099(16)30024-X","article-title":"Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines","volume":"16","author":"McMullan","year":"2016","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.cmi.2026.09.005_bib38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jiac.2023.02.012","article-title":"Pharmacokinetics of intravenous daptomycin in Japanese pediatric patients: Pharmacokinetic comparisons supporting dosing recommendations in Japanese pediatric patients","volume":"29","author":"Ishii","year":"2023","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"1","key":"10.1016\/j.cmi.2026.09.005_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac014","article-title":"Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE) - An open-labelled pilot randomized controlled trial","volume":"4","author":"Campbell","year":"2022","journal-title":"JAC-Antimicrobial Resistance"},{"key":"10.1016\/j.cmi.2026.09.005_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/INF.0000000000004529","article-title":"Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old With Infections Treated With Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study","volume":"44","author":"Bradley","year":"2025","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"3","key":"10.1016\/j.cmi.2026.09.005_bib41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.idnow.2021.02.004","article-title":"Antibiotic lock therapy for the conservative treatment of long-term intravenous catheter-related infections in adults and children: When and how to proceed? Guidelines for clinical practice 2020","volume":"51","author":"Albert","year":"2021","journal-title":"Infectious Diseases Now"},{"key":"10.1016\/j.cmi.2026.09.005_bib42","first-page":"1","article-title":"Recommendations on the diagnosis and the use of antibiotics for early-onset sepsis in preterm infants: Consensus of the expert panel from Hunan Province","volume":"22","year":"2020","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"4","key":"10.1016\/j.cmi.2026.09.005_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/INF.0000000000001445","article-title":"Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis: A Randomized Controlled Trial","volume":"36","author":"Shabaan","year":"2017","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.cmi.2026.09.005_bib44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jpc.13518","article-title":"Seven versus 10 days antibiotic therapy for culture-proven neonatal sepsis: A randomised controlled trial","volume":"53","author":"Rohatgi","year":"2017","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1016\/j.cmi.2026.09.005_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12098-021-03794-6","article-title":"Ten Versus 14 Days of Antibiotic Therapy in Culture-Proven Neonatal Sepsis: A Randomized, Controlled Trial","volume":"89","author":"Reddy","year":"2022","journal-title":"Indian Journal of Pediatrics"},{"key":"10.1016\/j.cmi.2026.09.005_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.635517","article-title":"Latamoxef for Neonates With Early-Onset Neonatal Sepsis: A Study Protocol for a Randomized Controlled Trial","volume":"12","author":"Qi","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cmi.2026.09.005_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1745-6215-12-215","article-title":"Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial","volume":"12","author":"Lutsar","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2026.09.005_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/0009922817717327","article-title":"Preemptive Ethanol Lock Therapy in Pediatric Hematology\/Oncology Patients With Catheter-Associated Bloodstream Infection: Impact on Length of Stay, Cost, and Catheter Salvage","volume":"57","author":"McGrath","year":"2018","journal-title":"Clinical Pediatrics"},{"key":"10.1016\/j.cmi.2026.09.005_bib49","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.52711\/0974-360X.2022.00177","article-title":"Efficacy and safety of Colistin-Imipenem\/Cilastatin combination Therapy for Multidrug-Resistant Gram-Negative Bacteria Infections in Critically Ill Pediatric Patients","volume":"15","author":"Mancy","year":"2022","journal-title":"Research Journal of Pharmacy and Technology"},{"key":"10.1016\/j.cmi.2026.09.005_bib50","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/cid\/ciae289","article-title":"Does Adjunctive Clindamycin Have a Role in Staphylococcus aureus Bacteremia? A Protocol for the Adjunctive Treatment Domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) Randomized Controlled Trial","volume":"79","author":"Anpalagan","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.cmi.2026.09.005_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229380","article-title":"Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial","volume":"15","author":"Lutsar","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2026.09.005_bib52","series-title":"WHO recommendations for management of serious bacterial infections in infants aged 0\u201359 days","author":"World Health","year":"2024"},{"key":"10.1016\/j.cmi.2026.09.005_bib53","first-page":"1","article-title":"Recommendations on the diagnosis and the use of antibiotics for early-onset sepsis in preterm infants: consensus of the expert panel from Hunan Province","volume":"22","author":"HNMQC","year":"2020","journal-title":"Chinese Journal of Contemporary Pediatrics"},{"key":"10.1016\/j.cmi.2026.09.005_bib54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/tropej\/fmq012","article-title":"Ten days vs. 14 days antibiotic therapy in culture-proven neonatal sepsis","volume":"56","author":"Gathwala","year":"2010","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.cmi.2026.09.005_bib55","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.arcped.2013.02.065","article-title":"[Intravenous antibiotic therapy for acute hematogenous osteomyelitis in children: short versus long course]","volume":"20","author":"Bouchoucha","year":"2013","journal-title":"Arch Pediatr"},{"issue":"2","key":"10.1016\/j.cmi.2026.09.005_bib56","first-page":"107","volume":"26","year":"2024","journal-title":"PekingUniversity Third Hospital; Editorial Department of Chinese Journal of Contemporary Pediatrics"},{"key":"10.1016\/j.cmi.2026.09.005_bib57","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/jrpp.JRPP_19_68","article-title":"A randomized clinical trial evaluating the efficacy of colistin loading dose in critically ill children","volume":"8","author":"Fatehi","year":"2019","journal-title":"J Res Pharm Pract"},{"key":"10.1016\/j.cmi.2026.09.005_bib58","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/INF.0000000000001926","article-title":"Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia","volume":"37","author":"Arrieta","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2026.09.005_bib59","series-title":"Ethanol Lock for the Salvage of Infected Long-term Vascular Access [Internet]","year":"2010"},{"issue":"8","key":"10.1016\/j.cmi.2026.09.005_bib60","first-page":"499","article-title":"Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis treatment? A randomized clinical trial","volume":"49","author":"Taheri","year":"2011","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.cmi.2026.09.005_bib61","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jiac.2021.11.019","article-title":"Efficacy and safety of daptomycin in Japanese pediatric participants with complicated skin and soft tissue infections or bacteremia caused by gram-positive cocci","volume":"28","author":"Iwata","year":"2022","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.cmi.2026.09.005_bib62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12185-020-03031-4","article-title":"Meropenem versus piperacillin\/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin\/tazobactam as a 1-h drip infusion four times a day","volume":"113","author":"Kobayashi","year":"2021","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cmi.2026.09.005_bib63","series-title":"Once Daily Versus Twice Daily Dosing of Ceftriaxone in Children with Enteric Fever: Randomized Controlled Trial","author":"Kumar","year":"2012"},{"key":"10.1016\/j.cmi.2026.09.005_bib64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/INF.0000000000003314","article-title":"Duration of Antibiotic Therapy in Neonatal Gram-negative Bacterial Sepsis-10 Days Versus 14 Days A Randomized Controlled Trial","volume":"41","author":"Fursule","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2026.09.005_bib65","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1651-2227.2010.01687.x","article-title":"Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis","volume":"99","author":"Metsvaht","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.cmi.2026.09.005_bib66","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jac\/dkab413","article-title":"Simultaneous pharmacokinetic\/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis","volume":"77","author":"Gastine","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.cmi.2026.09.005_bib67","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/pch\/pxy049","article-title":"Diagnosis and management of acute osteoarticular infections in children","volume":"23","author":"Le Saux","year":"2018","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.cmi.2026.09.005_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijid.2021.05.044","article-title":"Comparison of piperacillin plasma concentrations in a prospective randomised trial of extended infusion versus intermittent bolus of piperacillin\/tazobactam in paediatric patients","volume":"108","author":"Chongcharoenyanon","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2026.09.005_bib69","doi-asserted-by":"crossref","DOI":"10.1093\/tropej\/fmad036","article-title":"Ten- vs. 14-day antibiotic therapy for culture-positive neonatal sepsis","volume":"69","author":"Islam","year":"2023","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.cmi.2026.09.005_bib70","series-title":"Evidence review for antibiotics for treating late-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment [NICE Evidence Review]","author":"NIf","year":"2021"},{"key":"10.1016\/j.cmi.2026.09.005_bib71","first-page":"1009","article-title":"[Recommendations for antibiotic use in hospitalized preterm infants with late-onset sepsis in the neonatal intensive care unit]","volume":"26","author":"Center","year":"2024","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"Suppl 1","key":"10.1016\/j.cmi.2026.09.005_bib72","first-page":"S88","article-title":"Turkish Neonatal Society guideline on neonatal infections-diagnosis and treatment","volume":"53","author":"Satar","year":"2018","journal-title":"Turk Pediatri Ars"},{"key":"10.1016\/j.cmi.2026.09.005_bib73","unstructured":"Zemlin M, Berger A, Franz A, Gille C, Hartel C, Kuster H, et al. Bakterielle Infektionen bei Neugeborenen. 2019. Report No.: 024\/008."},{"issue":"4","key":"10.1016\/j.cmi.2026.09.005_bib74","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.cmi.2026.09.005_bib75","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.09.005_bib76","series-title":"Guidance for best practices for clinical trials","author":"Organization","year":"2024"},{"key":"10.1016\/j.cmi.2026.09.005_bib77","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41390-021-01883-y","article-title":"Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials","volume":"91","author":"Henry","year":"2022","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.cmi.2026.09.005_bib78","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/antibiotics11050627","article-title":"Variation in Antibiotic Treatment Failure Outcome Definitions in Randomised Trials and Observational Studies of Antibiotic Prescribing Strategies: A Systematic Review and Narrative Synthesis","volume":"11","author":"Neill","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"10.1016\/j.cmi.2026.09.005_bib79","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/antibiotics13111035","article-title":"An Update on Recent Clinical Trial Data in Bloodstream Infection","volume":"13","author":"Stewart","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2026.09.005_bib80","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.cmi.2026.09.005_bib81","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/11599120-000000000-00000","article-title":"Valuation of the Child Health Utility 9D Index","volume":"30","author":"Stevens","year":"2012","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.cmi.2026.09.005_bib82","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/pedi.13134","article-title":"Measurement properties of Patient Reported Outcomes Measurement Information System domains for children with type 1 diabetes","volume":"22","author":"Singh","year":"2021","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"10.1016\/j.cmi.2026.09.005_bib83","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jval.2026.01.025","article-title":"Impact of Respiratory Infections on Health-Related Quality of Life Among Children: Using PedsQL, EQ-5D-Y, and EQ-TIPS","volume":"29","author":"Kitano","year":"2026","journal-title":"Value in Health"},{"key":"10.1016\/j.cmi.2026.09.005_bib84","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s13063-024-08512-z","article-title":"A multicentric, randomized, controlled clinical trial to study the impact of bedside model-informed precision dosing of vancomycin in critically ill children-BENEFICIAL trial","volume":"25","author":"DeCock","year":"2024","journal-title":"Trials"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26005197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26005197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:13:16Z","timestamp":1793909596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26005197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":84,"alternative-id":["S1198743X26005197"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.09.005","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardizing outcomes in paediatric bloodstream infection antibiotic trials: a scoping review","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}